Edward Rudnic - QRxPharma CEO
CEO
Dr. Edward M. Rudnic, Ph.D., serves as Chief Executive Officer of QRxPharma Limited effective May 2, 2014. He served as Chief Operating Officer from February 14, 2012 until May 2, 2014. He holds BS in Pharmacy, MS in Pharmaceuticals and Doctorate in Philosophy from University of Rhode Island. He founded Advancis Pharmaceuticals . His previous experience also includes executive and managerial positions with Shire Pharmaceuticals, Pharmavene, Schering Plough and E.R. Squibb. since 2014.
| Age | 59 |
| Tenure | 10 years |
| Phone | 61 3 9092 0475 |
| Web | https://www.qrxpharma.com |
QRxPharma Management Efficiency
The company has return on total asset (ROA) of (54.14) % which means that it has lost $54.14 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (120.31) %, meaning that it generated substantial loss on money invested by shareholders. QRxPharma's management efficiency ratios could be used to measure how well QRxPharma manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 4 records | CEO Age | ||
| Roni Dor | Sapiens International | 56 | |
| Mark Bristow | Barrick Gold Corp | 61 | |
| D Bristow | Barrick Gold Corp | 61 | |
| Roni AlDor | Sapiens International | 63 | |
Management Performance
| Return On Equity | -120.31 | |||
| Return On Asset | -54.14 |
QRxPharma Leadership Team
Elected by the shareholders, the QRxPharma's board of directors comprises two types of representatives: QRxPharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of QRxPharma. The board's role is to monitor QRxPharma's management team and ensure that shareholders' interests are well served. QRxPharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, QRxPharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Janette Dixon, Sr. VP of Global Bus. Devel. | ||
| Chris Campbell, CFO, Company Secretary | ||
| Anthony Jefferies, Director | ||
| Edward Rudnic, CEO | ||
| John Rainbow, Director | ||
| Timothy Heesh, Director | ||
| Beth Burnside, Sr. VP of Regulatory Affairs and Compliance | ||
| Cameron Jones, Company Secretary |
QRxPharma Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is QRxPharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -120.31 | |||
| Return On Asset | -54.14 | |||
| Current Valuation | (247.69 K) | |||
| Shares Outstanding | 164.19 M | |||
| Shares Owned By Insiders | 23.71 % | |||
| Shares Owned By Institutions | 12.03 % | |||
| Price To Earning | (3.26) X | |||
| Price To Book | 0.10 X | |||
| Price To Sales | 150.01 X | |||
| Revenue | 2.41 K |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as QRxPharma using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in QRxPharma Pink Sheet
If you are still planning to invest in QRxPharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the QRxPharma's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |